Non-lytic antibiotic treatment in community-acquired pneumococcal pneumonia does not attenuate inflammation: the PRISTINE trial

BACKGROUND: The inflammatory response in pneumococcal infection is primarily driven by immunoreactive bacterial cell wall components [lipoteichoic acid (LTA)]. An acute release of these components occurs when pneumococcal infection is treated with β-lactam antibiotics. OBJECTIVES: We hypothesized th...

Descripción completa

Detalles Bibliográficos
Autores principales: Groeneveld, Geert H, van der Reyden, Tanny J, Joosten, Simone A, Bootsma, Hester J, Cobbaert, Christa M, de Vries, Jutte J C, Kuijper, Ed J, van Dissel, Jaap T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6640306/
https://www.ncbi.nlm.nih.gov/pubmed/31106377
http://dx.doi.org/10.1093/jac/dkz207

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6640306/
https://www.ncbi.nlm.nih.gov/pubmed/31106377
http://dx.doi.org/10.1093/jac/dkz207

Ejemplares similares